Literature DB >> 22156203

Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats.

Cao Huang1, Jianbin Tong, Fangfang Bi, Hongxia Zhou, Xu-Gang Xia.   

Abstract

Amyotrophic lateral sclerosis (ALS) is characterized by progressive motor neuron degeneration, which ultimately leads to paralysis and death. Mutation of TAR DNA binding protein 43 (TDP-43) has been linked to the development of an inherited form of ALS. Existing TDP-43 transgenic animals develop a limited loss of motor neurons and therefore do not faithfully reproduce the core phenotype of ALS. Here, we report the creation of multiple lines of transgenic rats in which expression of ALS-associated mutant human TDP-43 is restricted to either motor neurons or other types of neurons and skeletal muscle and can be switched on and off. All of these rats developed progressive paralysis reminiscent of ALS when the transgene was switched on. Rats expressing mutant TDP-43 in motor neurons alone lost more spinal motor neurons than rats expressing the disease gene in varying neurons and muscle cells, although these rats all developed remarkable denervation atrophy of skeletal muscles. Intriguingly, progression of the disease was halted after transgene expression was switched off; in rats with limited loss of motor neurons, we observed a dramatic recovery of motor function, but in rats with profound loss of motor neurons, we only observed a moderate recovery of motor function. Our finding suggests that mutant TDP-43 in motor neurons is sufficient to promote the onset and progression of ALS and that motor neuron degeneration is partially reversible, at least in mutant TDP-43 transgenic rats.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156203      PMCID: PMC3248298          DOI: 10.1172/JCI59130

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  BAC transgenic mice express enhanced green fluorescent protein in central and peripheral cholinergic neurons.

Authors:  Yvonne N Tallini; Bo Shui; Kai Su Greene; Ke-Yu Deng; Robert Doran; Patricia J Fisher; Warren Zipfel; Michael I Kotlikoff
Journal:  Physiol Genomics       Date:  2006-08-29       Impact factor: 3.107

2.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

Authors:  P C Wong; C A Pardo; D R Borchelt; M K Lee; N G Copeland; N A Jenkins; S S Sisodia; D W Cleveland; D L Price
Journal:  Neuron       Date:  1995-06       Impact factor: 17.173

3.  Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.

Authors:  Cédric Raoul; Toufik Abbas-Terki; Jean-Charles Bensadoun; Sandrine Guillot; Georg Haase; Jolanta Szulc; Christopher E Henderson; Patrick Aebischer
Journal:  Nat Med       Date:  2005-03-13       Impact factor: 53.440

4.  TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.

Authors:  Hans Wils; Gernot Kleinberger; Jonathan Janssens; Sandra Pereson; Geert Joris; Ivy Cuijt; Veerle Smits; Chantal Ceuterick-de Groote; Christine Van Broeckhoven; Samir Kumar-Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-03       Impact factor: 11.205

5.  TDP-43: an emerging new player in neurodegenerative diseases.

Authors:  I-Fan Wang; Lien-Szu Wu; C-K James Shen
Journal:  Trends Mol Med       Date:  2008-10-15       Impact factor: 11.951

6.  Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Authors:  Ian R A Mackenzie; Eileen H Bigio; Paul G Ince; Felix Geser; Manuela Neumann; Nigel J Cairns; Linda K Kwong; Mark S Forman; John Ravits; Heather Stewart; Andrew Eisen; Leo McClusky; Hans A Kretzschmar; Camelia M Monoranu; J Robin Highley; Janine Kirby; Teepu Siddique; Pamela J Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

7.  Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice.

Authors:  Christian S Lobsiger; Severine Boillee; Melissa McAlonis-Downes; Amir M Khan; M Laura Feltri; Koji Yamanaka; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-27       Impact factor: 11.205

8.  Restricted expression of mutant SOD1 in spinal motor neurons and interneurons induces motor neuron pathology.

Authors:  Lijun Wang; Kamal Sharma; Han-Xiang Deng; Teepu Siddique; Gabriella Grisotti; Erdong Liu; Raymond P Roos
Journal:  Neurobiol Dis       Date:  2007-10-23       Impact factor: 5.996

9.  Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.

Authors:  Lionel M Igaz; Linda K Kwong; Edward B Lee; Alice Chen-Plotkin; Eric Swanson; Travis Unger; Joe Malunda; Yan Xu; Matthew J Winton; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

10.  Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

Authors:  E Buratti; T Dörk; E Zuccato; F Pagani; M Romano; F E Baralle
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

View more
  54 in total

1.  Temporal Expression of Mutant TDP-43 Correlates with Early Amyotrophic Lateral Sclerosis Phenotype and Motor Weakness.

Authors:  Qihua Chen; Jinxia Zhou; Cao Huang; Bo Huang; Fangfang Bi; Hongxia Zhou; Bo Xiao
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

2.  Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes.

Authors:  Arianna Russo; Raffaella Scardigli; Federico La Regina; Melissa E Murray; Nicla Romano; Dennis W Dickson; Benjamin Wolozin; Antonino Cattaneo; Marcello Ceci
Journal:  Hum Mol Genet       Date:  2017-04-15       Impact factor: 6.150

3.  Reactive astrocytes secrete lcn2 to promote neuron death.

Authors:  Fangfang Bi; Cao Huang; Jianbin Tong; Guang Qiu; Bo Huang; Qinxue Wu; Fang Li; Zuoshang Xu; Robert Bowser; Xu-Gang Xia; Hongxia Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

Review 4.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

Review 5.  Biological Spectrum of Amyotrophic Lateral Sclerosis Prions.

Authors:  Magdalini Polymenidou; Don W Cleveland
Journal:  Cold Spring Harb Perspect Med       Date:  2017-11-01       Impact factor: 6.915

6.  Profiling the genes affected by pathogenic TDP-43 in astrocytes.

Authors:  Cao Huang; Bo Huang; Fangfang Bi; Linda H Yan; Jianbin Tong; Jufang Huang; Xu-Gang Xia; Hongxia Zhou
Journal:  J Neurochem       Date:  2014-02-09       Impact factor: 5.372

7.  Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis.

Authors:  Chunxing Yang; Hongyan Wang; Tao Qiao; Bin Yang; Leonardo Aliaga; Linghua Qiu; Weijia Tan; Johnny Salameh; Diane M McKenna-Yasek; Thomas Smith; Lingtao Peng; Melissa J Moore; Robert H Brown; Huaibin Cai; Zuoshang Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

8.  CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration.

Authors:  Nicole F Liachko; Pamela J McMillan; Chris R Guthrie; Thomas D Bird; James B Leverenz; Brian C Kraemer
Journal:  Ann Neurol       Date:  2013-07-08       Impact factor: 10.422

9.  Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats.

Authors:  Jianbin Tong; Cao Huang; Fangfang Bi; Qinxue Wu; Bo Huang; Xionghao Liu; Fang Li; Hongxia Zhou; Xu-Gang Xia
Journal:  EMBO J       Date:  2013-05-28       Impact factor: 11.598

10.  Increased Ubqln2 expression causes neuron death in transgenic rats.

Authors:  Bo Huang; Qinxue Wu; Hongxia Zhou; Cao Huang; Xu-Gang Xia
Journal:  J Neurochem       Date:  2016-10       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.